Genetic factors affecting gene transcription and catalytic activity of UDP-glucuronosyltransferases in human liver

Abstract

The aim of this study was to discover cis- and trans-acting factors significantly affecting mRNA expression and catalytic activity of human hepatic UDP-glucuronosyltransferases (UGTs). Transcription levels of five major hepatic UGT1A (UGT1A1, UGT1A3, UGT1A4, UGT1A6 and UGT1A9) and five UGT2B (UGT2B4, UGT2B7, UGT2B10, UGT2B15 and UGT2B17) genes were quantified in human liver tissue samples (n = 125) using real-time PCR. Glucuronidation activities of 14 substrates were measured in 47 livers. We genotyped 167 tagSNPs (single-nucleotide polymorphisms) in UGT1A (n = 43) and UGT2B (n = 124), as well as the known functional UGT1A1*28 and UGT2B17 CNV (copy number variation) polymorphisms. Transcription levels of 15 transcription factors (TFs) known to regulate these UGTs were quantified. We found that UGT expression and activity were highly variable among the livers (median and range of coefficient of variations: 135%, 74-217% and 52%, 39-105%, respectively). CAR, PXR and ESR1 were found to be the most important trans-regulators of UGT transcription (median and range of correlation coefficients: 46%, 6-58%; 47%, 9-58%; and 52%, 24-75%, respectively). Hepatic UGT activities were mainly determined by UGT gene transcription levels. Twenty-one polymorphisms were significantly (FDR-adjusted P < 0.05) associated with mRNA expression and/or activities of UGT1A1, UGT1A3 and UGT2B17. We found novel SNPs in the UGT2B17 CNV region accounting for variability in UGT2B17 gene transcription and testosterone glucuronidation rate, in addition to that attributable to the UGT2B17 CNV. Our study discovered novel pharmacogenetic markers and provided detailed insight into the genetic network regulating hepatic UGTs.

Figure 1.

Heatmap of correlations between UGT gene transcription (A), UGT activities (B), UGT gene transcription and activity (C) and TFs and UGT gene transcription (D). MPA, mycophenolic acid; M3G, morphine-3-glucuronide; M6G, morphine-6-glucuronide. The color codes indicate correlation coefficients.

Figure 2.

Genotype–phenotype correlations between UGT2B17 CNV and UGT2B17 gene transcription (A) and UGT2B17 activity (B); as well as between rs6817882 and UGT2B17 gene transcription (C) and UGT2B17 activity (D). The genotype of rs6817882 among hemizygous (one copy of UGT2B17) and diploid (two copies of UGT2B17) samples was shown separately. UGT expression is relative to TBP expression.